Elanco Animal Health Incorporated Common Stock (ELAN)

Price$23.67

Value ScoreC

Growth ScoreB

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)-3.64%

Price vs S&P 500 (4W)0.98%

VGM Score54.42

Market Capitalization$11.91B

P/E Ratio (Annual)38.83x

All Metrics

P/CF (Annual)21.27x

Book Value / Share (Quarterly)$13.02

P/TBV (Annual)3.58x

Revenue Growth (3Y)2.25%

Cash Flow / Share (Quarterly)$0.63

Price vs S&P 500 (YTD)-5.54%

Gross Margin (TTM)55.06%

Net Profit Margin (TTM)-4.95%

EPS (TTM)$-0.51

10-Day Avg Trading Volume7.60M

EPS Excl Extra (TTM)$-0.51

Revenue Growth (5Y)7.59%

EPS (Annual)$-0.47

ROI (Annual)-2.20%

Gross Margin (Annual)54.99%

Net Profit Margin (5Y Avg)-7.42%

Cash / Share (Quarterly)$0.86

P/E Basic Excl Extra (TTM)364.59x

Revenue Growth QoQ (YoY)14.92%

EPS Growth (5Y)29.95%

P/E Normalized (Annual)38.83x

ROA (Last FY)-1.74%

Revenue Growth TTM (YoY)10.53%

EBITD / Share (TTM)$0.75

ROE (5Y Avg)-5.05%

Operating Margin (TTM)-3.70%

Cash Flow / Share (Annual)$0.57

P/B Ratio1.83x

P/B Ratio (Quarterly)1.84x

Net Income / Employee (Annual)$-24,700

EV / Revenue (TTM)3.16x

Net Interest Coverage (TTM)3.08x

ROA (TTM)-1.80%

EPS Growth QoQ (YoY)-16.10%

EV / EBITDA (TTM)41.60x

EPS Incl Extra (Annual)$-0.47

Current Ratio (Annual)2.17x

Quick Ratio (Quarterly)0.95x

3-Month Avg Trading Volume5.53M

52-Week Price Return76.41%

EV / Free Cash Flow (Annual)54.49x

P/E Incl Extra (TTM)364.59x

Revenue / Employee (TTM)$520,500

Tangible BV / Share (Quarterly)$6.56

P/S Ratio (Annual)2.53x

Asset Turnover (Annual)0.35x

52-Week High$27.72

Operating Margin (5Y Avg)-1.82%

EPS Excl Extra (Annual)$-0.47

CapEx CAGR (5Y)-2.35%

Tangible BV CAGR (5Y)8.49%

26-Week Price Return12.29%

Quick Ratio (Annual)0.93x

13-Week Price Return-8.93%

Total Debt / Equity (Annual)0.61x

Current Ratio (Quarterly)2.16x

Enterprise Value$15.47B

Revenue / Share Growth (5Y)5.09%

Asset Turnover (TTM)0.36x

Book Value / Share Growth (5Y)-6.01%

Revenue / Employee (Annual)$501,600

Inventory Turnover (Annual)1.28x

Pretax Margin (Annual)-4.75%

Cash / Share (Annual)$1.10

3-Month Return Std Dev56.15%

Gross Margin (5Y Avg)55.61%

Net Income / Employee (TTM)$-25,700

EBITDA CAGR (5Y)28.45%

EBITDA Interim CAGR (5Y)12.82%

ROE (Last FY)-3.54%

Net Interest Coverage (Annual)3.08x

EPS Basic Excl Extra (Annual)$-0.47

P/FCF (TTM)33.74x

Receivables Turnover (TTM)4.76x

EV / Free Cash Flow (TTM)49.13x

Total Debt / Equity (Quarterly)0.61x

EPS Incl Extra (TTM)$-0.51

Receivables Turnover (Annual)5.62x

ROI (TTM)-2.26%

P/S Ratio (TTM)2.43x

Pretax Margin (5Y Avg)-6.89%

Revenue / Share (Annual)$9.50

Tangible BV / Share (Annual)$6.32

Forward P/E22.48x

Free OCF CAGR (5Y)70.08%

Price vs S&P 500 (52W)48.20%

P/E Ratio (TTM)364.59x

EPS Growth TTM (YoY)-82.48%

Year-to-Date Return5.39%

5-Day Price Return9.76%

EPS Normalized (Annual)$-0.47

ROA (5Y Avg)-2.21%

Net Profit Margin (Annual)-4.92%

Month-to-Date Return6.62%

Cash Flow / Share (TTM)$-0.92

EBITD / Share (Annual)$0.68

Operating Margin (Annual)-4.35%

LT Debt / Equity (Annual)0.57x

P/CF (TTM)20.64x

ROI (5Y Avg)-2.66%

P/E Excl Extra (TTM)364.59x

LT Debt / Equity (Quarterly)0.60x

EPS Basic Excl Extra (TTM)$-0.51

P/TBV (Quarterly)3.65x

P/B Ratio (Annual)1.72x

Inventory Turnover (TTM)1.33x

Pretax Margin (TTM)-4.03%

Book Value / Share (Annual)$13.17

Price vs S&P 500 (13W)-18.68%

Net Margin Growth (5Y)28.06%

Beta1.71x

P/FCF (Annual)41.94x

Revenue / Share (TTM)$9.67

ROE (TTM)-3.64%

52-Week Low$13.09

vGradeC

gGradeB

mGradeB

vgmGradeC

Show chart for

Earnings Surprise History

Q1 260.40est. 0.35

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.27

4.30

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$23.67
LLYEli Lilly & Co.	D	B	B	$1082.20
JNJJohnson & Johnson	C	C	C	$223.51
ABBVABBVIE INC.	D	C	C	$212.93
MRKMerck & Co., Inc.	C	C	C	$115.17
NVSNovartis AG	C	C	C	$145.68
AZNAstraZeneca PLC	D	B	C	$179.71
NVONovo-Nordisk A/S	B	B	C	$44.07
PFEPfizer Inc.	B	C	C	$25.63
ABTAbbott Laboratories	C	C	D	$87.78
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$34.64

About

Elanco Animal Health is a global pharmaceutical company serving the companion and food animal markets with products sold in over 90 countries. The company's portfolio spans cattle, sheep, goats, swine, and companion animals, built through a combination of internal development and strategic acquisitions that have strengthened its market position.